Category Archives: "Partners"

Novartis statement on reported case of PML
Novartis Statement on Reported Case of PML Novartis has been informed of a patient with progressive multifocal leukoencephalopathy [...]
FDA accepts biologics license application for ZINBRYTA for treatment of multiple sclerosis
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS BLA Acceptance Follows [...]
Mallinckrodt research fellowship award program announcement
Mallinckrodt Research Fellowship Award Program Announcement Mallinckrodt Pharmaceuticals is pleased to announce the Research Fellowship [...]
FDA accepts filing of BETACONNECT for RRMS patients taking BETASERON
FDA Accepts Filing of BETACONNECT™* for Relapsing-Remitting Multiple Sclerosis Patients Taking BETASERON® (interferon beta-1b) Offers [...]
International survey identifies opportunities for improving multiple sclerosis treatment satisfaction
International Survey from Biogen Identifies Opportunities for Improving MS Treatment Satisfaction Many Factors Influence Patient [...]
TECFIDERA Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients TECFIDERA Provides Robust and [...]
EMA validates marketing authorization application for ZINBRYTA for treatment of multiple sclerosis
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of [...]
Teva Neuroscience & Access Health team up for special multiple sclerosis awareness show: thursday, 3/5
Teva Neuroscience & Access Health Team Up for Special MS Awareness Show: Thursday, March 5 As Multiple Sclerosis Awareness Week [...]
Acorda announces data from first clinical trial of remyelinating antibody in multiple sclerosis
Acorda Announces Safety and Tolerability Data from First Clinical Trial of Remyelinating Antibody in Multiple Sclerosis Phase 1 trial [...]
First multiple sclerosis patients in the U.S. receive Genzyme’s Lemtrada following FDA approval
First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval – Lemtrada now available in the U.S. two weeks post [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last